Dental Soft-tissue Regeneration Market by Product Type (Autografts, Synthetic Biomaterials, Collagen-based Membranes), Application (Implantology, Periodontology), End User (Dental Hospitals, DSO's & Independent Clinics), Region - Global Forecast to 2030

The dental soft-tissue regeneration market is projected to grow from USD 0.38 billion in 2025 to USD 0.53 billion by 2030, at a CAGR of 6.8% during this period. This market has experienced significant growth due to several factors, including the rising incidence of periodontal diseases, increasing awareness of oral health, and the growing trend of cosmetic dentistry. Furthermore, initiatives to develop healthcare infrastructure in underdeveloped regions are driving the demand for more dental treatments and related products. Additionally, advancements in regenerative biomaterials have also played a crucial role in the market's expansion.

“By product type, the collagen-based membranes segment accounted for the largest share of the dental soft-tissue regeneration market in 2024.”

Based on product type, the collagen-based membranes segment is expected to dominate the dental soft-tissue regeneration market due to several factors. Collagen-based membranes act as barriers that guide tissue growth, supporting the healing of periodontal and implant-related defects. Additionally, these membranes can integrate with surrounding tissues and promote the growth of new connective tissue. Furthermore, innovations in regenerative biomaterials are also contributing to the growth of this market.

“By application, the implantology segment accounted for the largest share of the dental soft-tissue regeneration market in 2024.”

The implantology segment is expected to hold the largest share of the dental soft-tissue regeneration market due to factors such as the growing aging population, increased awareness of oral health, and rising demand for cosmetic dentistry. Products like collagen membranes, soft-tissue grafts, and advanced bioactive materials are increasingly utilized to promote healing in peri-implant soft tissues. Additionally, innovations in soft-tissue regenerative solutions and heightened awareness of dental aesthetics further contribute to the growth of the dental soft-tissue regeneration market.

“By region, North America accounted for the largest share of the dental soft-tissue regeneration market.”

Due to several factors, North America is expected to account for the largest share of the dental soft-tissue regeneration market during the forecast period. The region has advanced healthcare infrastructure and high healthcare expenditure rates, which drive the demand for sophisticated dental care treatments. Additionally, the significant increase in the geriatric population, who are more susceptible to periodontal diseases, accounts for a considerable portion of the treatments needed in North America.

Favorable government policies, reimbursement frameworks for dental care treatments, and high patient insurance coverage further encourage access to advanced dental care. Moreover, ongoing research and development in dental technologies and biomaterials support the expansion of this market in the region.

A breakdown of the primary participants (supply side) for the dental soft-tissue regeneration market referred to in this report is provided below:

• By Company Type: Tier 1 (35%), Tier 2 (40%), and Tier 3 (25%)
• By Designation: C-level Executives (45%), Director-level Executives (35%), and Others (20%)
• By Region: North America (27%), Europe (25%), Asia Pacific (30%), Latin America (8%), and the Middle East & Africa (10%)

Prominent players in the dental soft-tissue regeneration market are Geistlich Pharma AG (Switzerland), DENTSPLY Sirona (US), Institut Straumann AG (Switzerland), Zimvie Inc. (US), Henry Schein, Inc. (US), AbbVie Inc. (US), Advanced Medical Solutions Group Plc (UK), Tissue Regenix (UK), Septodont Holding (France), Medical Consult Implants GmbH (Germany), Meccellis (US), Regedent Ag (Switzerland), Regenity (US), Envista (US), AD Surgical (US), LifeNet Health (US), B. & B. Dental S.R.L. (Italy), Alpha-Bio Tec. Ltd. (Israel), Lasak S.R.O. (Czechia), KeystoneDentalGroup (US), Neoss AG (Switzerland), BEGO GmbH Co. KG (Germany), Biotech Dental (France), Samyang Holdings Corporation (South Korea), and RTI Surgical (US).

Research Coverage:

The report examines the dental soft-tissue regeneration market and seeks to estimate its market size and future growth potential across various segments, including product type, application, end user, and region. Additionally, the report features a competitive analysis of the key players in this market, including their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report is designed to assist both market leaders and new entrants in the dental soft-tissue regeneration market by providing close estimates of revenue figures. It will help stakeholders understand the competitive landscape, enabling them to better position their businesses and plan effective go-to-market strategies. Additionally, the report offers insights into the current trends in the market, including key drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

• Analysis of key drivers (rising prevalence of periodontal diseases, rising awareness and growing demand for cosmetic dentistry, advancements in biomaterials, and advancements in regenerative technology), restraints (inadequate reimbursement and high cost of dental services and dearth of trained dental practitioners), opportunities (consolidation of dental practices and rising DSO activity, growing focus on emerging economies and rising disposable income levels, and growing dental tourism in emerging countries), and challenges (pricing pressure faced by prominent market players, and stringent regulatory environment).
• Market Penetration: It contains comprehensive information on products offered by the key players in the global dental soft-tissue regeneration market. The report covers various segments, including product type, application, end user, and region.
• Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global dental soft-tissue regeneration market.
• Market Development: Thorough knowledge and analysis of the profitable rising markets by type, application, end user, and region.
• Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global dental soft-tissue regeneration market.
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global dental soft-tissue regeneration market.

Show more